Clough Capital Partners L P Zai Lab LTD Transaction History

Clough Capital Partners L P

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$54.9 - $105.21 $123,525 - $236,722	-2,250 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$105.0 - $178.37 $6.89 Million - $11.7 Million	-65,650 Reduced 96.69%	2,250 $237,000
Q2 2021 Aug 16, 2021	SELL	$125.11 - $180.0 $3.07 Million - $4.41 Million	-24,510 Reduced 26.52%	67,900 $12 Million
Q1 2021 May 17, 2021	SELL	$126.27 - $191.71 $2.92 Million - $4.43 Million	-23,130 Reduced 20.02%	92,410 $12.3 Million
Q4 2020 Feb 16, 2021	SELL	$81.94 - $135.34 $4.56 Million - $7.54 Million	-55,680 Reduced 32.52%	115,540 $15.6 Million
Q3 2020 Nov 17, 2020	BUY	$73.3 - $89.48 $1.63 Million - $2 Million	22,300 Added 14.97%	171,220 $14.2 Million
Q2 2020 Aug 14, 2020	SELL	$48.82 - $82.53 $4.85 Million - $8.2 Million	-99,300 Reduced 40.0%	148,920 $12.2 Million
Q1 2020 May 15, 2020	BUY	$39.1 - $62.9 $1.37 Million - $2.2 Million	34,920 Added 16.37%	248,220 $12.8 Million
Q4 2019 Feb 14, 2020	BUY	$29.79 - $43.06 $6.35 Million - $9.18 Million	213,300 New	213,300 $8.87 Million

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.52B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Clough Capital Partners L P, based on Form 13F filings with the SEC.

Stay updated on Clough Capital Partners L P with notifications on news.